
This study compared fall-related outcomes in older adults initiating gabapentin versus duloxetine for conditions like diabetic neuropathy and fibromyalgia. Among 57,086 participants aged 65+, gabapentin users showed a lower hazard of fall-related visits over six months (HR 0.52, 95% CI: 0.43–0.64) compared to duloxetine users. However, there was no difference in severe fall-related events, such as hip fractures or hospitalizations. Results remained consistent across sensitivity analyses. Claims data limitations, including potential underreporting of falls, should be considered.
Like
Save
Share